Invivyd Inc. (IVVD) Stock Analysis

Invivyd Inc. (IVVD) is a publicly traded company in the HEALTHCARE sector. It trades at $1.14, carries a market capitalization of $359.42M. This page summarizes the public market data, fundamentals, and frequently asked questions for IVVD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.14
• Market Cap: $359.42M
• EPS: $-0.29
• 52-Week High: $3.07
• 52-Week Low: $0.48

Market Sentiment

Invivyd Inc. currently has a Neutral sentiment score of 0.05.

About Invivyd Inc.

Invivyd Inc. is a clinical-stage biopharmaceutical firm headquartered in Waltham, Massachusetts, focused on the discovery and development of cutting-edge antibody-based therapies for infectious diseases. Leveraging proprietary technologies and deep expertise in immunology, the company is committed to addressing substantial unmet medical needs through its robust pipeline of innovative solutions. By positioning itself at the forefront of antibody therapy advancements, Invivyd is well-equipped t...

GNG Research Analysis

GNG Research scores Invivyd Inc. (IVVD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IVVD.

Frequently Asked Questions

Does IVVD pay dividends?

Invivyd Inc. (IVVD) does not currently pay a regular dividend.

What is IVVD's market cap?

Invivyd Inc. (IVVD) has a market capitalization of $359.42M with a current stock price of $1.14.